Showing results (51-60 of 113) with videos related to
Sort By:
Pageof 12
Cancer Research|November 3, 2017
Interleukin-27 Exerts Its Antitumor Effects by Promoting Differentiation of Hematopoietic Stem Cells to M1 MacrophagesYukino Chiba, Izuru Mizoguchi, Junichi Furusawa, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine productionToshiyuki Owaki, Masayuki Asakawa, Noriko Morishima, et al.Plos One|October 25, 2013
IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent mannerYukino Chiba, Izuru Mizoguchi, Kana Mitobe, et al.Gels (Basel, Switzerland)|April 25, 2025
Wound Healing Enhancement and Physical Characterization of Bioadhesive Poly(acrylic acid)/Polyvinylpyrrolidone Complex GelsAyaka Oouchi, Tomoko Ito, Yasuhiro Katahira, et al.Journal of Virology|August 17, 2004
Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic miceMasanori Matsui, Osamu Moriya, Maria Laura Belladonna, et al.Communications Biology|March 5, 2022
Rap1 prevents colitogenic Th17 cell expansion and facilitates Treg cell differentiation and distal TCR signalingSayaka Ishihara, Tsuyoshi Sato, Noriyuki Fujikado, et al.Immunobiology|August 29, 2012
IL-27 promotes nitric oxide production induced by LPS through STAT1, NF-κB and MAPKsMotomu Shimizu, Kiyoshi Ogura, Izuru Mizoguchi, et al.Cancer Research|June 17, 2006
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanomaShuntaro Oniki, Hiroshi Nagai, Tatsuya Horikawa, et al.BJU International|March 26, 2011
IL-23 gene therapy for mouse bladder tumour cell linesTomomi Kuramoto, Reona Fujii, Hiroshi Nagai, et al.Cancer Research|February 12, 2004
Potent antitumor activity of interleukin-27Masayuki Hisada, Sadahiro Kamiya, Koji Fujita, et al.Pageof 12